Athersys Gross Margin

The Gross Margin of Athersys Inc (ATHX) is 7775.20%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

Athersys Gross Margin - Historical Value

Date	Value
2022-12-31	7775.20%

Athersys Gross Margin - Peers Comparison

Ticker	Name	Value
TNXP	Tonix Pharmaceuticals Holding Corp	23.07%
AQB	AquaBounty Technologies Inc	-518.02%
CFRX	ContraFect Corp	7775.20%
CRBP	Corbus Pharmaceuticals Holdings Inc	7775.20%
CTIC	CTI Biopharma Corp	93.49%
VRTX	Vertex Pharmaceuticals Inc	86.11%
950200.KQ	Psomagen Inc	23.13%
ALPN	Alpine Immune Sciences Inc	7775.20%
ALT	Altimmune Inc	100.47%
EQ	Equillium Inc	7775.20%
GILD	Gilead Sciences Inc	78.26%
MRNA	Moderna Inc	70.06%
950160.KQ	Kolon TissueGene Inc	11.72%
AMGN	Amgen Inc	68.71%
INFI	Infinity Pharmaceuticals Inc	39.72%
ISR	IsoRay Inc	23.01%
VTVT	vTv Therapeutics Inc	7775.20%
BBLG	Bone Biologics Corp	7775.20%
HOOK	HOOKIPA Pharma Inc	7775.20%
OTLK	Outlook Therapeutics Inc	7775.20%
TTOO	T2 Biosystems Inc	-113.58%
ABBV	Abbvie Inc	69.99%
SPPI	Spectrum Pharmaceuticals Inc	82.28%
SVRA	Savara Inc	100.00%
950220.KQ	Neoimmunetech Inc	7775.20%
CASI	CASI Pharmaceuticals Inc	55.88%
ELDN	Eledon Pharmaceuticals Inc	7775.20%
FREQ	Frequency Therapeutics Inc	44.73%
GLSI	Greenwich Lifesciences Inc	7775.20%
LOGC	LogicBio Therapeutics Inc	16.28%
ADMA	ADMA Biologics Inc	51.48%
MEIP	MEI Pharma Inc	100.00%
RCEL	AVITA Medical Inc	86.60%
REGN	Regeneron Pharmaceuticals Inc	87.01%